Joan Brunet
Joan Brunet
Hereditary Cancer Program, Catalan Institute of Oncology
Verified email at
Cited by
Cited by
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology and Prevention Biomarkers 21 (1), 134-147, 2012
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS Genet 9 (3), e1003212, 2013
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A Vazquez‐Martin, R Colomer, J Brunet, R Lupu, JA Menendez
Cell proliferation 41 (1), 59-85, 2008
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
JA Menendez, A Vazquez-Martin, R Colomer, J Brunet, ...
BMC cancer 7 (1), 80, 2007
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and …
F Bellido, M Pineda, G Aiza, R Valdés-Mas, M Navarro, DA Puente, ...
Genetics in Medicine 18 (4), 325-332, 2016
Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
KB Kuchenbaecker, L McGuffog, D Barrowdale, A Lee, P Soucy, J Dennis, ...
JNCI: Journal of the National Cancer Institute 109 (7), 2017
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population‐based study
S de Sanjosé, M Leone, V Berez, A Izquierdo, R Font, JM Brunet, T Louat, ...
International journal of cancer 106 (4), 588-593, 2003
New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis
L Valle, E Hernández-Illán, F Bellido, G Aiza, A Castillejo, MI Castillejo, ...
Human molecular genetics 23 (13), 3506-3512, 2014
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
LS Schmidt, ML Nickerson, D Angeloni, GM Glenn, MCM Walther, ...
The Journal of urology 172 (4 Part 1), 1256-1261, 2004
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
T Puig, A Vázquez-Martín, J Relat, J Pétriz, JA Menéndez, R Porta, ...
Breast cancer research and treatment 109 (3), 471-479, 2008
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes
L Feliubadaló, A Lopez-Doriga, E Castellsagué, J Del Valle, M Menéndez, ...
European Journal of Human Genetics 21 (8), 864-870, 2013
Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.
L De Andres, J Brunet, A Lopez-Pousa, J Burgués, M Vega, JM Tabernero, ...
Journal of clinical oncology 13 (6), 1493-1500, 1995
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa™)-induced changes in the expression and nucleo-cytoplasmic …
L Ferrer-Soler, A Vazquez-Martin, J Brunet, JA Menendez, R De Llorens, ...
International journal of molecular medicine 20 (1), 3-10, 2007
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer
CA Maxwell, J Benítez, L Gómez-Baldó, A Osorio, N Bonifaci, ...
PLoS Biol 9 (11), e1001199, 2011
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the …
C Oliveras-Ferraros, A Vazquez-Martin, E López-Bonet, B Martín-Castillo, ...
International journal of oncology 33 (6), 1165-1176, 2008
Germline mutations in FAN1 cause hereditary colorectal cancer by impairing DNA repair
N Seguí, LB Mina, C Lázaro, R Sanz-Pamplona, T Pons, M Navarro, ...
Gastroenterology 149 (3), 563-566, 2015
BRCA1 and acetyl‐CoA carboxylase: the metabolic syndrome of breast cancer
J Brunet, A Vazquez‐Martin, R Colomer, B Graña‐Suarez, ...
Molecular Carcinogenesis: Published in cooperation with the University of …, 2008
The system can't perform the operation now. Try again later.
Articles 1–20